The “Sepsis Diagnostics – Global Market Outlook (2016-2022)” report has been added to Research and Markets’ offering.
The Global Sepsis Diagnostics market is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%.
This life-threatening condition of Sepsis arises when the body’s response to infection injures its own tissues and organs; the rise in number of the situations is demanding more diagnostics.
Rising health concerns such as Cancer, Diabetes, Major Trauma, and Burns etc. are depleting the immune system among all age groups, which has given rise to the demand for the Sepsis diagnostics market.
Moreover, increasing surgical procedures, exponential rise in incidence of hospital-acquired infections and growth in the number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness and shortage of skilled staff are the hindering the same.
– Automated Diagnostics
– Conventional Diagnostics
– Assay Kits & Reagents
– Blood Culture Media
– Fungal Sepsis
– Bacterial Sepsis
– Gram-Negative Bacterial Sepsis
– Gram-Positive Bacterial Sepsis
– Other Pathogens
– Flow Cytometry
– Molecular Diagnostics
– Laboratory Testing
– Point-Of-Care Testing
Key Topics Covered:
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Sepsis Diagnostics market, By Method
6 Global Sepsis Diagnostics market, By Product
7 Global Sepsis Diagnostics market, By Pathogen
8 Global Sepsis Diagnostics market, By Technology
9 Global Sepsis Diagnostics market, By Application
10 Global Sepsis Diagnostics market, By Geography
11 Key Developments
12 Company Profiling
– Abbott Diagnostics
– Beckman Coulter (Danaher)
– Becton, Dickinson & Co. (BD)
– Bio-Rad Laboratories
– Bruker Corporation
– Chembio Diagnostic Systems
– Nanosphere, Inc.
– Ortho-Clinical Diagnostics
– Roche Diagnostics
– Siemens Healthcare Diagnostics
– T2 Biosystems, Inc.
– Thermo Fisher Scientific
– Trinity Biotech
For more information about this report visit https://www.researchandmarkets.com/research/29wz2s/sepsis